Variant report
Variant | esv3493509 |
---|---|
Chromosome Location | chr12:58027949-58029355 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr12:58028220-58028370 | AG10803 | skin: | n/a | n/a |
2 | CTCF | chr12:58027980-58028130 | SAEC | small airway: | n/a | n/a |
3 | CTCF | chr12:58028194-58028325 | Hela-S3 | cervix: | n/a | n/a |
4 | CTCF | chr12:58028231-58028301 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr12:58028039-58028059 | GM10266 | blood: | n/a | n/a |
6 | CTCF | chr12:58028140-58028290 | HCT-116 | colon: | n/a | n/a |
7 | CTCF | chr12:58028198-58028352 | HepG2 | liver: | n/a | n/a |
8 | JUN | chr12:58028737-58028962 | HepG2 | liver: | n/a | chr12:58028877-58028890 |
9 | JUND | chr12:58028727-58029014 | HepG2 | liver: | n/a | n/a |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:57940164..57942070-chr12:58025601..58028102,2 | MCF-7 | breast: | |
2 | chr12:58026571..58028240-chr12:58118727..58121626,2 | MCF-7 | breast: | |
3 | chr12:58026019..58028946-chr12:58148453..58151531,3 | K562 | blood: | |
4 | chr12:57935626..57940631-chr12:58026197..58030320,5 | K562 | blood: | |
5 | chr12:57997114..58001112-chr12:58025485..58030490,5 | MCF-7 | breast: | |
6 | chr12:57983391..57985108-chr12:58026747..58028430,2 | MCF-7 | breast: | |
7 | chr12:58004618..58008024-chr12:58024930..58028098,5 | MCF-7 | breast: | |
8 | chr12:58024113..58026472-chr12:58028228..58030289,2 | K562 | blood: | |
9 | chr12:57983573..57987941-chr12:58024849..58028209,5 | MCF-7 | breast: | |
10 | chr12:57908910..57916403-chr12:58022622..58028885,15 | K562 | blood: | |
11 | chr12:57908910..57916122-chr12:58022622..58031573,17 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
B4GALNT1 | TF binding region |
ENSG00000139266 | chromatin interactions |
ENSG00000240771 | chromatin interactions |
ENSG00000135446 | chromatin interactions |
ENSG00000178498 | chromatin interactions |
ENSG00000166986 | chromatin interactions |
ENSG00000135454 | chromatin interactions |
ENSG00000175197 | chromatin interactions |
ENSG00000208028 | chromatin interactions |
ENSG00000257499 | chromatin interactions |
ENSG00000175203 | chromatin interactions |
ENSG00000255737 | chromatin interactions |
ENSG00000166987 | chromatin interactions |
ENSG00000166908 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547092766 | chr12:58027953-58027954 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
2 | rs143198408 | chr12:58027965-58027966 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
3 | rs201486187 | chr12:58027992-58027993 | Weak transcription Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
4 | rs543450930 | chr12:58028020-58028021 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
5 | rs12296818 | chr12:58028037-58028038 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs577088012 | chr12:58028044-58028045 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
7 | rs4397894 | chr12:58028049-58028050 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
8 | rs185185790 | chr12:58028051-58028052 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
9 | rs149575786 | chr12:58028053-58028054 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
10 | rs142710812 | chr12:58028055-58028056 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
11 | rs145038850 | chr12:58028058-58028059 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
12 | rs548364305 | chr12:58028064-58028065 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
13 | rs559664384 | chr12:58028080-58028081 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
14 | rs561052349 | chr12:58028126-58028127 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
15 | rs575572182 | chr12:58028142-58028143 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
16 | rs531654401 | chr12:58028234-58028235 | Weak transcription | TF binding regionChromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
17 | rs544560489 | chr12:58028268-58028269 | Weak transcription | TF binding regionChromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
18 | rs571279964 | chr12:58028283-58028284 | Weak transcription | TF binding regionChromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
19 | rs372349757 | chr12:58028304-58028305 | Weak transcription | TF binding regionChromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
20 | rs202216644 | chr12:58028342-58028343 | Weak transcription | TF binding regionChromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
21 | rs34271193 | chr12:58028361-58028362 | Weak transcription | TF binding regionChromatin interactive region | 11 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs200259419 | chr12:58028363-58028364 | Weak transcription | TF binding regionChromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
23 | rs189218233 | chr12:58028380-58028381 | Weak transcription | Chromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
24 | rs536448766 | chr12:58028452-58028453 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
25 | rs555159115 | chr12:58028463-58028464 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
26 | rs192575585 | chr12:58028466-58028467 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
27 | rs537113899 | chr12:58028487-58028488 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
28 | rs147522030 | chr12:58028494-58028495 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
29 | rs369422168 | chr12:58028513-58028514 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
30 | rs576796581 | chr12:58028535-58028536 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
31 | rs140083336 | chr12:58028556-58028557 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
32 | rs372285811 | chr12:58028592-58028593 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
33 | rs184828989 | chr12:58028596-58028597 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
34 | rs188074810 | chr12:58028743-58028744 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
35 | rs12578587 | chr12:58028746-58028747 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs181073477 | chr12:58028770-58028771 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
37 | rs563109625 | chr12:58028825-58028826 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
38 | rs531714155 | chr12:58028852-58028853 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
39 | rs6581147 | chr12:58028863-58028864 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs528430725 | chr12:58028867-58028868 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
41 | rs114637968 | chr12:58028914-58028915 | Weak transcription | TF binding regionChromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
42 | rs532447160 | chr12:58028948-58028949 | Weak transcription | TF binding regionChromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
43 | rs547720602 | chr12:58029058-58029059 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
44 | rs566252797 | chr12:58029065-58029066 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
45 | rs201752146 | chr12:58029104-58029105 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
46 | rs12298852 | chr12:58029243-58029244 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
47 | rs12312189 | chr12:58029250-58029251 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
48 | rs7958927 | chr12:58029261-58029262 | Weak transcription | Chromatin interactive region | 7 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs377404253 | chr12:58029277-58029278 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
50 | rs548819596 | chr12:58029283-58029284 | Weak transcription | Chromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 21909424 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Autism | 20531469 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glycogen storage disease | 18421352 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:58027200-58028000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr12:58027200-58033600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr12:58027600-58028200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr12:58027600-58034000 | Weak transcription | K562 | blood |
5 | chr12:58027800-58028000 | Flanking Active TSS | Hela-S3 | cervix |
6 | chr12:58027800-58030600 | Weak transcription | A549 | lung |
7 | chr12:58028000-58028200 | Bivalent Enhancer | Primary T cells effector/memory enriched fromperipheralblood | blood |